Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Myriad Genetics Inc (MYGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,420,907
  • Shares Outstanding, K 73,272
  • Annual Sales, $ 772,600 K
  • Annual Income, $ 131,100 K
  • 60-Month Beta 0.57
  • Price/Sales 3.17
  • Price/Cash Flow 16.83
  • Price/Book 2.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.38
  • Number of Estimates 4
  • High Estimate 0.38
  • Low Estimate 0.37
  • Prior Year 0.31
  • Growth Rate Est. (year over year) +22.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.00 +18.57%
on 03/07/19
34.33 -3.29%
on 03/14/19
+1.50 (+4.73%)
since 02/21/19
3-Month
26.05 +27.45%
on 02/06/19
34.33 -3.29%
on 03/14/19
+5.79 (+21.12%)
since 12/21/18
52-Week
26.05 +27.45%
on 02/06/19
50.44 -34.18%
on 09/04/18
+2.49 (+8.11%)
since 03/21/18

Most Recent Stories

More News
Myriad to Present 18 Studies at the 2019 Annual Clinical Genetics Meeting

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that its Myriad Women's Health business unit will present data from 18 studies at the 2019 Annual Clinical Genetics...

MYGN : 33.44 (+1.21%)
Myriad's myPath Melanoma Test Awarded Medicare Coverage

The latest nod from Medicare Coverage for Myriad's (MYGN) myPath Melanoma test is likely to boost top-line results in the near term.

HOLX : 47.64 (+0.72%)
ITGR : 86.47 (+1.24%)
MYGN : 33.44 (+1.21%)
VEEV : 127.63 (+2.46%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Cytokinetics Inc (CYTK , ADMS , MYGN , FPRX , ALDR )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

CYTK : 10.18 (-0.10%)
ADMS : 8.09 (+1.00%)
MYGN : 33.44 (+1.21%)
Myriad's myPath(R) Melanoma Test Receives Medicare Coverage

Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that the Medicare Administrative Contractor Palmetto GBA MolDx has issued a final local coverage determination...

MYGN : 33.44 (+1.21%)
Watch for Myriad Genetics to Potentially Pullback After Gaining 1.54% Yesterday

Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $29.11 to a high of $29.62. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of...

MYGN : 33.44 (+1.21%)
SmarTrend Watching for Potential Pullback in Shares of Myriad Genetics After 1.54% Gain

Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $29.11 to a high of $29.62. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of...

MYGN : 33.44 (+1.21%)
Why Is Myriad (MYGN) Down 0.5% Since Last Earnings Report?

Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MYGN : 33.44 (+1.21%)
Report: Exploring Fundamental Drivers Behind ArcelorMittal, Cohen & Steers, Myriad Genetics, Lexington Realty Trust, NorthWestern, and Chesapeake Utilities -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ArcelorMittal (NYSE:MT), Cohen...

LXP : 9.21 (+1.77%)
MT : 22.20 (-1.42%)
MYGN : 33.44 (+1.21%)
CNS : 41.43 (+0.93%)
NWE : 70.58 (+1.16%)
CPK : 93.59 (+1.94%)
Prostate Cancer Diagnostics Market Size is Projected to be Around USD 15800 million by 2024

MaketStudyReport.com adds a new Global Prostate Cancer Diagnostics Market Research Report for the period of 2019-2024 that shows the growth of the market is rising at a 7.9% CAGR from 2019 to 2024.

MYGN : 33.44 (+1.21%)
Myriad Genetics Falls 3.30% on Heavy Volume: Watch For Potential Rebound

Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $30.74 to a high of $31.75. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $31.23...

MYGN : 33.44 (+1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MYGN with:

Business Summary

Myriad Genetics, Inc. is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties. Myriad is the pioneer and leader in molecular diagnostics, offering...

See More

Key Turning Points

2nd Resistance Point 33.91
1st Resistance Point 33.47
Last Price 33.44
1st Support Level 32.78
2nd Support Level 32.53

See More

52-Week High 50.44
Fibonacci 61.8% 41.12
Fibonacci 50% 38.24
Fibonacci 38.2% 35.37
Last Price 33.44
52-Week Low 26.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar